INOGEN INC (INGN) Stock Fundamental Analysis

NASDAQ:INGN • US45780L1044

6.18 USD
+0.08 (+1.31%)
At close: Mar 2, 2026
6.1807 USD
+0 (+0.01%)
After Hours: 3/2/2026, 8:00:02 PM
Overview Stock Chart Technical Analysis Fundamental Analysis Analyst Ratings Earnings Estimates Financials Ownership News
Fundamental Rating

3

Overall INGN gets a fundamental rating of 3 out of 10. We evaluated INGN against 184 industry peers in the Health Care Equipment & Supplies industry. The financial health of INGN is average, but there are quite some concerns on its profitability. While showing a medium growth rate, INGN is valued expensive at the moment.


Dividend Valuation Growth Profitability Health

2

1. Profitability

1.1 Basic Checks

  • INGN had negative earnings in the past year.
  • In the past year INGN has reported a negative cash flow from operations.
  • In the past 5 years INGN always reported negative net income.
  • The reported operating cash flow has been mixed in the past 5 years: INGN reported negative operating cash flow in multiple years.
INGN Yearly Net Income VS EBIT VS OCF VS FCFINGN Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 50M -50M -100M

1.2 Ratios

  • INGN has a Return On Assets of -7.62%. This is in the better half of the industry: INGN outperforms 64.13% of its industry peers.
  • Looking at the Return On Equity, with a value of -11.83%, INGN is in the better half of the industry, outperforming 66.85% of the companies in the same industry.
Industry RankSector Rank
ROA -7.62%
ROE -11.83%
ROIC N/A
ROA(3y)-17.05%
ROA(5y)-14.62%
ROE(3y)-27.5%
ROE(5y)-22.48%
ROIC(3y)N/A
ROIC(5y)N/A
INGN Yearly ROA, ROE, ROICINGN Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 -20 -40

1.3 Margins

  • INGN has a Gross Margin of 44.24%. This is in the lower half of the industry: INGN underperforms 62.50% of its industry peers.
  • In the last couple of years the Gross Margin of INGN has remained more or less at the same level.
  • The Profit Margin and Operating Margin are not available for INGN so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 44.24%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y2.83%
GM growth 5Y-0.25%
INGN Yearly Profit, Operating, Gross MarginsINGN Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 20 -20 40

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

6

2. Health

2.1 Basic Checks

  • INGN does not have a ROIC to compare to the WACC, probably because it is not profitable.
  • Compared to 1 year ago, INGN has more shares outstanding
  • Compared to 5 years ago, INGN has more shares outstanding
  • There is no outstanding debt for INGN. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
INGN Yearly Shares OutstandingINGN Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 5M 10M 15M 20M 25M
INGN Yearly Total Debt VS Total AssetsINGN Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 100M 200M 300M 400M

2.2 Solvency

  • INGN has an Altman-Z score of 1.52. This is a bad value and indicates that INGN is not financially healthy and even has some risk of bankruptcy.
  • INGN has a Altman-Z score of 1.52. This is comparable to the rest of the industry: INGN outperforms 55.43% of its industry peers.
  • INGN has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Altman-Z 1.52
ROIC/WACCN/A
WACC9.94%
INGN Yearly LT Debt VS Equity VS FCFINGN Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 100M 200M 300M

2.3 Liquidity

  • A Current Ratio of 3.12 indicates that INGN has no problem at all paying its short term obligations.
  • INGN has a Current ratio of 3.12. This is comparable to the rest of the industry: INGN outperforms 57.61% of its industry peers.
  • INGN has a Quick Ratio of 2.71. This indicates that INGN is financially healthy and has no problem in meeting its short term obligations.
  • With a decent Quick ratio value of 2.71, INGN is doing good in the industry, outperforming 61.41% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 3.12
Quick Ratio 2.71
INGN Yearly Current Assets VS Current LiabilitesINGN Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 100M 200M 300M

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

4

3. Growth

3.1 Past

  • INGN shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 48.03%, which is quite impressive.
  • Looking at the last year, INGN shows a small growth in Revenue. The Revenue has grown by 3.86% in the last year.
  • The Revenue has been growing slightly by 2.48% on average over the past years.
EPS 1Y (TTM)48.03%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%36.59%
Revenue 1Y (TTM)3.86%
Revenue growth 3Y-2.59%
Revenue growth 5Y2.48%
Sales Q2Q%2.05%

3.2 Future

  • INGN is expected to show quite a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 12.06% yearly.
  • Based on estimates for the next years, INGN will show a small growth in Revenue. The Revenue will grow by 6.31% on average per year.
EPS Next Y-8.65%
EPS Next 2Y12.06%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year4.79%
Revenue Next 2Y6.31%
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

  • When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
INGN Yearly Revenue VS EstimatesINGN Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 100M 200M 300M 400M
INGN Yearly EPS VS EstimatesINGN Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 0 1 -1 2 -2 -3

More info and screens

Find the best growth stocksShow best growing peers

0

4. Valuation

4.1 Price/Earnings Ratio

  • The Price/Earnings Ratio is negative for INGN. In the last year negative earnings were reported.
  • Besides the negative Price/Earnings Ratio, also the Forward Price/Earnings Ratio is negative for INGN. No positive earnings are expected for the next year.
Industry RankSector Rank
PE N/A
Fwd PE N/A
INGN Price Earnings VS Forward Price EarningsINGN Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 10 20

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
INGN Per share dataINGN EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 2 4 6 8 10

4.3 Compensation for Growth

  • A more expensive valuation may be justified as INGN's earnings are expected to grow with 12.06% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y12.06%
EPS Next 3YN/A

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

0

5. Dividend

5.1 Amount

  • No dividends for INGN!.
Industry RankSector Rank
Dividend Yield 0%

More info and screens

Find the best dividend stocksShow peers with best dividend

INOGEN INC

NASDAQ:INGN (3/2/2026, 8:00:02 PM)

After market: 6.1807 +0 (+0.01%)

6.18

+0.08 (+1.31%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Equipment & Supplies
Earnings (Last)02-24
Earnings (Next)05-05
Inst Owners72.63%
Inst Owner Change4.4%
Ins Owners2.18%
Ins Owner Change1.05%
Market Cap168.28M
Revenue(TTM)348.67M
Net Income(TTM)-22.75M
Analysts82.5
Price Target13.26 (114.56%)
Short Float %4.06%
Short Ratio3.84
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)35.38%
Min EPS beat(2)28.7%
Max EPS beat(2)42.07%
EPS beat(4)4
Avg EPS beat(4)41.59%
Min EPS beat(4)28.7%
Max EPS beat(4)50.73%
EPS beat(8)8
Avg EPS beat(8)40.93%
EPS beat(12)9
Avg EPS beat(12)21.6%
EPS beat(16)12
Avg EPS beat(16)22.98%
Revenue beat(2)0
Avg Revenue beat(2)-3.78%
Min Revenue beat(2)-5.8%
Max Revenue beat(2)-1.76%
Revenue beat(4)1
Avg Revenue beat(4)-1.57%
Min Revenue beat(4)-5.8%
Max Revenue beat(4)1.4%
Revenue beat(8)5
Avg Revenue beat(8)1.6%
Revenue beat(12)5
Avg Revenue beat(12)-0.59%
Revenue beat(16)8
Avg Revenue beat(16)-0.08%
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)-2.27%
EPS NQ rev (3m)-2.27%
EPS NY rev (1m)3.52%
EPS NY rev (3m)12.18%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)0%
Revenue NY rev (1m)0%
Revenue NY rev (3m)-0.69%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 0.48
P/FCF N/A
P/OCF N/A
P/B 0.88
P/tB 1.12
EV/EBITDA N/A
EPS(TTM)-0.79
EYN/A
EPS(NY)-0.86
Fwd EYN/A
FCF(TTM)-0.79
FCFYN/A
OCF(TTM)-0.41
OCFYN/A
SpS12.8
BVpS7.06
TBVpS5.54
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
Industry RankSector Rank
ROA -7.62%
ROE -11.83%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 44.24%
FCFM N/A
ROA(3y)-17.05%
ROA(5y)-14.62%
ROE(3y)-27.5%
ROE(5y)-22.48%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y2.83%
GM growth 5Y-0.25%
F-Score5
Asset Turnover1.17
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 50.26%
Cap/Sales 2.98%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 3.12
Quick Ratio 2.71
Altman-Z 1.52
F-Score5
WACC9.94%
ROIC/WACCN/A
Cap/Depr(3y)93.48%
Cap/Depr(5y)96.4%
Cap/Sales(3y)5.54%
Cap/Sales(5y)5.8%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)48.03%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%36.59%
EPS Next Y-8.65%
EPS Next 2Y12.06%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)3.86%
Revenue growth 3Y-2.59%
Revenue growth 5Y2.48%
Sales Q2Q%2.05%
Revenue Next Year4.79%
Revenue Next 2Y6.31%
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y26.62%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year121.03%
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-93.21%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-289.65%
OCF growth 3YN/A
OCF growth 5YN/A

INOGEN INC / INGN FAQ

What is the fundamental rating for INGN stock?

ChartMill assigns a fundamental rating of 3 / 10 to INGN.


What is the valuation status for INGN stock?

ChartMill assigns a valuation rating of 0 / 10 to INOGEN INC (INGN). This can be considered as Overvalued.


How profitable is INOGEN INC (INGN) stock?

INOGEN INC (INGN) has a profitability rating of 2 / 10.


How financially healthy is INOGEN INC?

The financial health rating of INOGEN INC (INGN) is 6 / 10.